Immunologic and non-immunologic complications of a third kidney transplantation

Korean J Intern Med. 2015 Sep;30(5):657-64. doi: 10.3904/kjim.2015.30.5.657. Epub 2015 Aug 27.

Abstract

Background/aims: Patients who undergo repeat kidney transplantations (KTs) are considered at high risk for experiencing immunologic and non-immunologic complications. In this study, we investigated the clinical outcomes, including medical and surgical complications, of patients who underwent a third KT at our center.

Methods: Between March 1969 and December 2012, a total of 2,110 KTs were performed at the Seoul St. Mary's Hospital. Of them, we examined 11 patients who underwent a third KT, and investigated the allograft outcomes and complication rates.

Results: The mean follow-up duration after KT was 72.4 ± 78.3 months. The mean age at KT was 38.2 ± 8.0 years, and seven patients (63.6%) were males. Nine patients (81.8%) underwent living-donor KT. A cross-match test yielded positive results in four of the nine patients, and all underwent pretransplant desensitization therapy. After KT, three patients (27.2%) showed delayed graft function. Acute rejection developed in four patients (36.4%), and surgical complications that required surgical correction occurred in three patients. Allograft failure developed due to acute rejection (n = 3) or chronic rejection (n = 1) in four patients. Allograft survival rates at 1, 5, and 10 years were 81.8%, 42.9%, and 42.9%, respectively; however, the allograft survival rate at 5 years was > 80% in patients who underwent KT only after results of the panel reactive antibody test became available.

Conclusions: Thus, a third KT procedure may be acceptable, although aggressive pretransplant immune monitoring and patient selection may be required to reduce the risks of acute rejection and surgical complications.

Keywords: Allograft survival; Complication; Kidney transplantation; Retransplantation.

MeSH terms

  • Acute Disease
  • Adult
  • Allografts
  • Chronic Disease
  • Delayed Graft Function / diagnosis
  • Delayed Graft Function / etiology*
  • Delayed Graft Function / therapy
  • Female
  • Graft Rejection / diagnosis
  • Graft Rejection / immunology*
  • Graft Rejection / therapy
  • Graft Survival
  • Histocompatibility*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Patient Selection
  • Reoperation
  • Republic of Korea
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents